US 8609395
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
granted A61KA61K38/00A61K39/00
Quick answer
US patent 8609395 (Agonist and antagonist peptides of carcinoembryonic antigen (CEA)) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K39/00, A61K48/00, A61P